| Membrane transporters in drug development KM Giacomini, SM Huang, DJ Tweedie, LZ Benet, KLR Brouwer, X Chu, ... Nature reviews Drug discovery 9 (3), 215, 2010 | 2687 | 2010 |
| Endocytic mechanisms for targeted drug delivery LM Bareford, PW Swaan Advanced drug delivery reviews 59 (8), 748-758, 2007 | 1009 | 2007 |
| Camptothecins H Ulukan, PW Swaan Drugs 62 (14), 2039-2057, 2002 | 335 | 2002 |
| Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration S Khanna, S Roy, H Ryu, P Bahadduri, PW Swaan, RR Ratan, CK Sen Journal of Biological Chemistry 278 (44), 43508-43515, 2003 | 324 | 2003 |
| Progress in predicting human ADME parameters in silico S Ekins, CL Waller, PW Swaan, G Cruciani, SA Wrighton, JH Wikel Journal of pharmacological and toxicological methods 44 (1), 251-272, 2000 | 307 | 2000 |
| Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability RB Kolhatkar, KM Kitchens, PW Swaan, H Ghandehari Bioconjugate chemistry 18 (6), 2054-2060, 2007 | 294 | 2007 |
| Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers AB Foraker, RJ Walczak, MH Cohen, TA Boiarski, CF Grove, PW Swaan Pharmaceutical research 20 (1), 110-116, 2003 | 229 | 2003 |
| Design, synthesis, cytoselective toxicity, structure–activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells H Zhou, S Wu, S Zhai, A Liu, Y Sun, R Li, Y Zhang, S Ekins, PW Swaan, ... Journal of medicinal chemistry 51 (5), 1242-1251, 2008 | 205 | 2008 |
| Transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers: influence of size, charge and fluorescent labeling KM Kitchens, RB Kolhatkar, PW Swaan, ND Eddington, H Ghandehari Pharmaceutical research 23 (12), 2818-2826, 2006 | 194 | 2006 |
| Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells KM Kitchens, AB Foraker, RB Kolhatkar, PW Swaan, H Ghandehari Pharmaceutical research 24 (11), 2138-2145, 2007 | 189 | 2007 |
| Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels RM Fryer, AK Hsu, H Nagase, GJ Gross Journal of Pharmacology and Experimental Therapeutics 294 (2), 451-457, 2000 | 189 | 2000 |
| Rapid identification of P-glycoprotein substrates and inhibitors C Chang, PM Bahadduri, JE Polli, PW Swaan, S Ekins Drug Metabolism and Disposition 34 (12), 1976-1984, 2006 | 161 | 2006 |
| Endocytosis inhibitors prevent poly (amidoamine) dendrimer internalization and permeability across Caco-2 cells KM Kitchens, RB Kolhatkar, PW Swaan, H Ghandehari Molecular Pharmaceutics 5 (2), 364-369, 2008 | 158 | 2008 |
| ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport‐mediated PK and DDIs in humans MJ Zamek‐Gliszczynski, CA Lee, A Poirier, J Bentz, X Chu, H Ellens, ... Clinical Pharmacology & Therapeutics 94 (1), 64-79, 2013 | 155 | 2013 |
| Towards a new age of virtual ADME/TOX and multidimensional drug discovery S Ekins, B Boulanger, PW Swaan, MAZ Hupcey Journal of computer-aided molecular design 16 (5), 381-401, 2002 | 155 | 2002 |
| Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites S Ekins, C Chang, S Mani, MD Krasowski, EJ Reschly, M Iyer, ... Molecular pharmacology 72 (3), 592-603, 2007 | 152 | 2007 |
| Structural determinants of P-glycoprotein-mediated transport of glucocorticoids CR Yates, C Chang, JD Kearbey, K Yasuda, EG Schuetz, DD Miller, ... Pharmaceutical research 20 (11), 1794-1803, 2003 | 127 | 2003 |
| Current perspectives on the cellular uptake and trafficking of riboflavin AB Foraker, CM Khantwal, PW Swaan Advanced drug delivery reviews 55 (11), 1467-1483, 2003 | 126 | 2003 |
| Pharmacophore-based discovery of ligands for drug transporters C Chang, S Ekins, P Bahadduri, PW Swaan Advanced drug delivery reviews 58 (12-13), 1431-1450, 2006 | 124 | 2006 |
| Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4 K Köck, BC Ferslew, I Netterberg, K Yang, TJ Urban, PW Swaan, ... Drug metabolism and disposition 42 (4), 665-674, 2014 | 122 | 2014 |
Carl P. WeinerObstetrics and Gynecology, University of Kansas School of MedicineVerified email at kumc.edu
